COMMUNIQUÉS West-GlobeNewswire

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
20/08/2024
MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, [...]
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
20/08/2024
WARSAW, Ind., Aug. 20, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates
20/08/2024
WARRINGTON, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for [...]
Tectonic Therapeutic to Participate in September Investor Conferences
20/08/2024
WATERTOWN, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
Galapagos receives transparency notification from FMR LLC
20/08/2024
Mechelen, Belgium; 20 August 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Pursuant to Belgian transparency legislation 1 , [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
20/08/2024
Bagsværd, Denmark, 20 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland
20/08/2024
RIYADH, Saudi Arabia, Aug. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is further expanding its global footprint by participating in the 2024 International Association for [...]
Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals
20/08/2024
GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of Bora [...]
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
20/08/2024
Cutting-edge incision-free solution advances standard of care for women with uterine fibroids REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics ® , Inc. a privately-held women’s healthcare medical [...]
U.S. Oral Surgery Management Recognized by Dallas Business Journal as one of the Region’s Fastest Growing Companies
20/08/2024
IRVING, Texas, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The Dallas Business Journal has named Irving’s U.S. Oral Surgery Management ( USOSM ) to this year’s Fast 50 – a list of the 50 fastest growing companies in the Dallas- [...]
PanOmiQ Set’s New Benchmark with 100% Accuracy in Whole Genome Sequencing Testing
20/08/2024
BioAro’s Cutting-Edge AI-Powered Software is now available for a 15-day free trial CALGARY, Alberta, Aug. 20, 2024 (GLOBE NEWSWIRE) -- BioAro, a leading precision health and genomics company, is proud to announce a [...]
SPARK NS Awards Five Projects Up to $10 Million to Advance Academic Discoveries in Parkinson’s Disease from the Lab to the Clinic
20/08/2024
Academic research teams participate in a two-year translational research program that eliminates barriers that prevent promising discoveries from benefitting patients MENLO PARK, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE [...]
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
20/08/2024
HOUSTON, Aug. 20, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]
Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024
20/08/2024
Reduces operating expenses by 25% Pipeline surpasses $100 million in weighted opportunities across the government and manufacturing sectors DURHAM, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE [...]
Orion Corporation: Managers’ transactions – Liisa Hurme
20/08/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 20 AUGUST 2024 at 16.15 EEST Orion Corporation: Managers’ transactions – Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Legend Senior Living® Assumes Management of Crescent Fields Senior Living Community in Huntingdon Valley, Growing Portfolio to 60
20/08/2024
HUNTINGDON VALLEY, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Legend Senior Living, with headquarters in Wichita, KS, has entered into a management agreement with the owners of Crescent Fields at Huntingdon Valley to [...]
Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US
20/08/2024
August 20, 2024 Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility [...]
Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024
20/08/2024
CHICAGO and FORT WORTH, Texas, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for [...]
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
20/08/2024
WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new [...]

Pages